Ever year, millions of people die from heart disease. More often than not this disease is caused by one or more blockages within the arteries leading to the heart. Surgeons often are forced to perform a coronary artery bypass surgery in order to prevent eventual death of a patient. Such a procedure traditionally calls for the removal of an artery somewhere else in the patient’s body such as the leg, and the reimplantation of that artery to replace the blocked specimen. I have seen two of my grandparents undergo multiple bypass surgeries and can tell you firsthand, it can often be a difficult recovery, especially for the elderly.
Through the natural progression of science, eventually most bypass surgeries will not require the removal and reimplantation of a healthy artery back into the patient. Vascular grafts will eventually lead to faster, easier procedures for both surgeons and the patients themselves. This is why a great deal of research is currently underway to create reliable synthetic blood vessels which mimic natural ones. A successful vascular graft needs to be robust enough to withstand its constant use within the circulatory system, while also providing space for actual human cells to grow within it as the graft slowly decays within the body.
Currently a method called electrospinning has been utilized by researchers to create vascular grafts, but they’ve found that the structure of the resultant grafts are not nearly rigid enough to support use within the human body. Because of this, researchers, led by Yuanyuan Liu at Shanghai University’s Rapid Manufacturing Engineering Center, are looking for a better solution.
We’ve already seen that 3D bioprinting can be used for a variety of medical applications, and it seems as if the technology could eventually hold promise within dozens of applications within the healthcare industry. Realizing this, the aforementioned researchers turned to a form of 3D printing themselves called micro-imprinting, in combination with their electrospinning technique to develop a vascular graft which is more robust than the grafts that relied solely on the electrospinning process.
The new vascular grafts consist of three layers. Two outer layers are created by the electrospinning apparatus and consists of chitosan and polyvinyl alcohol, while the inner layer is 3D printed with poly-p-dioxanone (PPDO), using the micro-imprinting technique. These three layers result in a composite vascular graft with inherent mechanical properties which are superior to grafts created with electrospinning alone.
“The composite vascular grafts could be better candidates for blood vessel repair,” said Yuanyuan Liu, an associate professor at the Rapid Manufacturing Engineering Center.
Although we are likely years away from seeing these vascular grafts used within human clinical trials, much less entering the realm of bypass surgery, the team’s next step is to perform animal testing using samples of these grafts. If successful, such technology could certainly advance the treatment of one of the world’s leading causes of death, heart disease. Thanks to 3D printing this all may eventually be possible.
Let’s hear your thoughts on this story in the 3D Printed Artificial Blood Vessel forum thread on 3DPB.com
You May Also Like
3D Printing for Nerve Regeneration: Gelatin Methacrylate-Based Nerve Guidance Conduits
Chinese researchers delve deeply into tissue engineering, releasing the findings of their recent study in ‘3D printing of gelatin methacrylate-based nerve guidance conduits with multiple channels.’ While there have been...
Aalto University Develops a Novel Bioink for Cardiac Tissue Applications
Finland is one of Europe’s most forested nations. Over 70 percent of the country’s boreal forest is covered with spruce, pine, downy birch, and silver birch. But beyond the splendor...
3D Printing Healthcare Applications for the Elderly
3D printing has many applications in the healthcare industry, as it allows users to fabricate complex, cost-effective, patient-specific devices on-demand. In the same vein, 3D bioprinting is important for applications...
RMMS: The Regenerative Medicine Manufacturing Society Will Target Unmet Needs in 3D Bioprinting
To deal with the challenges in regenerative medicine, in 2018, pioneer bioprinting expert Anthony Atala announced the foundation of an organization dedicated solely to advancing the field through manufacturing. Known...
View our broad assortment of in house and third party products.